These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6408234)

  • 1. Carnitine deficiency with valproate therapy.
    Stumpf DA; Parker WD; Haas R
    J Pediatr; 1983 Jul; 103(1):175-6. PubMed ID: 6408234
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproate treatment and carnitine deficiency.
    Ohtani Y; Matsuda I
    Neurology; 1984 Aug; 34(8):1128-9. PubMed ID: 6431316
    [No Abstract]   [Full Text] [Related]  

  • 3. Carnitine deficiency: a possible mechanism for valproate hepatotoxicity.
    Coulter DL
    Lancet; 1984 Mar; 1(8378):689. PubMed ID: 6142383
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
    Matsuda I; Ohtani Y; Ninomiya N
    J Pediatr; 1986 Jul; 109(1):131-4. PubMed ID: 3088240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium valproate -- induced skeletal myopathy.
    Kasturi L; Sawant SP
    Indian J Pediatr; 2005 Mar; 72(3):243-4. PubMed ID: 15812121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between renal tubular dysfunction and serum carnitine deficiency in cases with valproate therapy].
    Ono H
    No To Hattatsu; 2009 Sep; 41(5):363-5. PubMed ID: 19764458
    [No Abstract]   [Full Text] [Related]  

  • 7. Valproate-induced hyperacute hyperammonemic coma in a patient with hypocarnitinemia.
    Sofi A; Herial NA; Ali II
    Am J Ther; 2013; 20(6):e703-5. PubMed ID: 20224318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine, valproate, and toxicity.
    Coulter DL
    J Child Neurol; 1991 Jan; 6(1):7-14. PubMed ID: 2002205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.
    Al-sharefi A; Bilous R
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26336183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine Deficiency in Chinese Children with Epilepsy on Valproate Monotherapy.
    Qiliang L; Wenqi S; Hong J
    Indian Pediatr; 2018 Mar; 55(3):222-224. PubMed ID: 29629695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A child with valproic acid-associated carnitine deficiency and carnitine-responsive cardiac dysfunction.
    Bratton SL; Garden AL; Bohan TP; French JW; Clarke WR
    J Child Neurol; 1992 Oct; 7(4):413-6. PubMed ID: 1281852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carnitine deficiency as an adverse effect of treatment with valproic acid].
    Opala G
    Neurol Neurochir Pol; 1990; 24(3-4):244-5. PubMed ID: 2131422
    [No Abstract]   [Full Text] [Related]  

  • 13. Carnitine deficiency and hyperammonemia associated with valproic acid therapy.
    Ohtani Y; Endo F; Matsuda I
    J Pediatr; 1982 Nov; 101(5):782-5. PubMed ID: 6813444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine deficiency caused by valproic acid.
    Castro-Gago M; Camiña F; Rodríguez-Segade S
    J Pediatr; 1992 Mar; 120(3):496. PubMed ID: 1538306
    [No Abstract]   [Full Text] [Related]  

  • 15. Muscle carnitine deficiency in patients using valproic acid.
    Shapira Y; Gutman A
    J Pediatr; 1991 Apr; 118(4 Pt 1):646-9. PubMed ID: 2007943
    [No Abstract]   [Full Text] [Related]  

  • 16. Valproate-induced coma with ketosis and carnitine insufficiency.
    Triggs WJ; Bohan TP; Lin SN; Willmore LJ
    Arch Neurol; 1990 Oct; 47(10):1131-3. PubMed ID: 2121122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnitine deficiency during valproic acid treatment.
    Van Wouwe JP
    Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation.
    Ono H
    Clin Exp Nephrol; 2019 Jan; 23(1):148-149. PubMed ID: 29679355
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of carnitine supplementation in pediatric patients receiving valproic acid therapy.
    Davis D; Farrington E
    Pediatr Nurs; 1992; 18(3):264-5. PubMed ID: 1625956
    [No Abstract]   [Full Text] [Related]  

  • 20. Carnitine does not improve weight loss outcomes in valproate-treated bipolar patients consuming an energy-restricted, low-fat diet.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Mann JI
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):503-7. PubMed ID: 17042889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.